Publicacions en què col·labora amb AMADO ANDRÉS BELMONTE (27)

2022

  1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

2020

  1. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

2016

  1. Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

    American Journal of Transplantation, Vol. 16, Núm. 7, pp. 2148-2157

2015

  1. Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Journal of Infection, Vol. 71, Núm. 5, pp. 561-570

  2. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646

  3. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 2, pp. 314-321

  4. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case–control study

    Infection, Vol. 43, Núm. 4, pp. 413-422

2014

  1. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation

    Transplant International, Vol. 27, Núm. 7, pp. 674-685

2013

  1. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

    Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139

  2. Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients

    Transplantation, Vol. 95, Núm. 5, pp. 688-693

  3. Hypocomplementemia in kidney transplant recipients: Impact on the risk of infectious complications

    American Journal of Transplantation, Vol. 13, Núm. 3, pp. 685-694

  4. Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors

    Transplantation Proceedings

  5. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients

    Transplant Infectious Disease, Vol. 15, Núm. 6, pp. 600-611

2012

  1. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection

    American Journal of Transplantation, Vol. 12, Núm. 10, pp. 2763-2773

2009

  1. A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients

    Clinical Transplantation, Vol. 23, Núm. 5, pp. 666-671

2006

  1. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients

    Transplantation, Vol. 82, Núm. 1, pp. 30-35

2005

  1. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients

    Transplantation Proceedings

  2. Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients

    Transplantation Proceedings

  3. Is double renal transplantation a risk factor for cytomegalovirus disease?

    Transplantation Proceedings

2002

  1. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 97